Furosemide 20mg tablets

国家: 英国

语言: 英文

来源: MHRA (Medicines & Healthcare Products Regulatory Agency)

有效成分:

Furosemide

可用日期:

Sovereign Medical Ltd

ATC代码:

C03CA01

INN（国际名称）:

Furosemide

剂量:

20mg

药物剂型:

Oral tablet

给药途径:

Oral

类:

No Controlled Drug Status

处方类型:

Valid as a prescribable product

產品總結:

BNF: 02020200; GTIN: 05021730031091

资料单张

PACKAGE LEAFLET: INFORMATION FOR THE USER
FUROSEMIDE 20 mg and 40 mg Tablets
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
s
+EEPTHISLEAFLET9OUMAYNEEDTOREADITAGAIN
s
)FYOUHAVEANYFURTHERQUESTIONSASKYOURDOCTOROR
PHARMACIST
s
4HISMEDICINEHASBEENPRESCRIBEDFORYOUONLY$ONOTPASSIT
ONTOOTHERS)TMAYHARMTHEMEVENIFTHEIRSIGNSOFILLNESSARE
THESAMEASYOURS
s
)FYOUGETANYSIDEEFFECTSTALKTOYOURDOCTORORPHARMACIST
4HISINCLUDESANYSIDEEFFECTSNOTLISTEDINTHISLEAFLET3EE
SECTION
WHAT IS IN THIS LEAFLET

7HAT&UROSEMIDE4ABLETSAREANDWHATTHEYAREUSEDFOR

7HATYOUNEEDTOKNOWBEFOREYOUTAKE&UROSEMIDE4ABLETS

(OWTOTAKE&UROSEMIDE4ABLETS

0OSSIBLESIDEEFFECTS

(OWTOSTORE&UROSEMIDE4ABLETS

#ONTENTSOFTHEPACKANDOTHERINFORMATION
1. WHAT FUROSEMIDE TABLETS ARE AND WHAT THEY ARE
USED FOR
4HENAMEOFYOURMEDICINEIS&UROSEMIDEMGANDMG
4ABLETSREFERREDTOAS&UROSEMIDE4ABLETSINTHISLEAFLET 
&UROSEMIDE4ABLETSCONTAINTHEACTIVEINGREDIENTFUROSEMIDE
WHICHBELONGSTOAGROUPOFMEDICINESKNOWNASLOOPDIURETICS
$IURETICSINCREASETHEAMOUNTOFURINEYOUPRODUCEBYMAKING
YOURKIDNEYSALLOWMOREWATERANDSALTSTOBEREMOVEDFROMYOUR
BODY
&UROSEMIDE4ABLETSAREUSEDTOTREATOEDEMAWHICHISABUILDUP
OFFLUIDINTHEBODYTISSUES4HEOEDEMACANBECAUSEDBYHEART
ORKIDNEYFAILURELIVERDAMAGEORANOBSTRUCTION)NSOMECASES
THEFLUIDMAYBUILDUPINYOURLEGSANDHANDSANDINOTHERCASES
INAIRSPACESOFYOURLUNGSPULMONARYOEDEMA &UROSEMIDE
4ABLETSHELPYOURKIDNEYTOREMOVESOMEOFTHEEXCESSFLUIDFROM
YOURBODY
&UROSEMIDE4ABLETSCANALSOBEUSEDTOTREATMILDTOMODERATE
HIGHBLOODPRESSUREEITHERONITSOWNORINCOMBINATIONWITH
OTHERDRUGS
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE
FUROSEMIDE TABLETS
DO NOT TAKE FUROSEMIDE TABLETS
s
IFYOUAREALLERGICTOFUROSEMIDEORANYOTHERINGREDIENTSOFTHIS
MEDICINELISTEDINSECTION 
s
IFYOUHAVESEVEREKIDNEYDAMAGEWHICHHASSTOPPEDTHEM
WORKINGPROPERLYANDPRODUCINGURINE
s
IFYOUHAVEVERYLOWLEVELSOFPOTASSIUMSODIUMOROTHER
ELECTROLYTESINYOURBLOODORLOWBLOODVOLUMEYOURDOCTOR
WILLBEABLETOADVISEYOU
s
IFYOUAREDEHYDRATED
s
IFYOUHAVELOWBLOODPRESSURE
s
IFYO

产品特点

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Furosemide 20mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains Furosemide 20mg
Excipient of known effect
Each 20 mg tablet contains 51 mg of lactose.
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablets.
White circular, flat tablets with bevelled edge, with a breakline and
embossed
“F/20” on one face. 6mm diameter.
The breakline is not intended for breaking the tablet.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
The treatment of oedema associated with congestive heart failure,
cirrhosis of
the liver, renal disease including nephrotic syndrome and pulmonary
oedema.
The treatment of peripheral oedema due to mechanical obstruction,
venous
insufficiency and mild to moderate hypertension (alone, or in
combination
with other antihypertensive agents in the treatment of more severe
cases).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Posology _
_Adults and children over 12 years _
_OEDEMA _
The initial adult dose is 40mg daily, reduced to 20mg daily or 40mg on
alternate days.
In some patients daily doses of 80mg or higher (given in divided
doses) may be
required.
Maintenance dose is 20 mg daily or 40 mg on alternate days, increased
in resistant
oedema to 80 mg daily.
_ _
_HYPERTENSION _
20-40mg twice daily; if 40mg twice daily does not lead to a clinically
satisfactory
response, the addition of other antihypertensive agents, rather than
an increase in the
dose of furosemide should be considered.
_Children under 12 years _
The usual daily dose is 1 to 3mg/kg body weight daily up to a maximum
total dose of
40mg/day.
_Elderly _
Dosage should be titrated until the required response is achieved
because in the
elderly furosemide is generally eliminated more slowly.
METHOD OF ADMINISTRATION
For oral use.
_ _
_Dosage adjustment may be required (see also section 4.4)_
Dosage adjustment may be necessary in patients with
•
hypoproteinaemia
•
liver congestion/dysfunction
_ _
_Concomitant administration o